Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Rogers Communications
RCI
$18.6B
| $10.1M | ﹤0.01% |
376,794
+166,661
| +79% | +$4.71M |
|
|
INN
1952
Summit Hotel Properties
INN
$700M
| $10M | ﹤0.01% |
1,848,480
+257,720
| +16% | +$1.64M |
|
1953
Blue Bird Corp
BLBD
$2.18B
| $10M | ﹤0.01% |
308,851
-9,337
| -3% | -$341K |
|
1954
Xerox
XRX
$425M
| $9.98M | ﹤0.01% |
2,066,576
+254,474
| +14% | +$1.91M |
|
1955
Century Aluminum
CENX
$5.07B
| $9.98M | ﹤0.01% |
537,727
-1,434
| -0.3% | -$27.6K |
|
1956
Vicor
VICR
$10.2B
| $9.97M | ﹤0.01% |
213,133
+761
| +0.4% | +$40.3K |
|
1957
iShares Core S&P US Value ETF
IUSV
$27.7B
| $9.96M | ﹤0.01% |
107,943
-10,539
| -9% | -$989K |
|
1958
Bristow Group
VTOL
$1.36B
| $9.89M | ﹤0.01% |
313,074
+34,936
| +13% | +$1.2M |
|
1959
Appian
APPN
$2.54B
| $9.83M | ﹤0.01% |
341,039
-7,893
| -2% | -$258K |
|
1960
Vita Coco
COCO
$3.6B
| $9.82M | ﹤0.01% |
320,283
-5,087
| -2% | -$181K |
|
1961
Universal Technical Institute
UTI
$1.59B
| $9.8M | ﹤0.01% |
381,650
+31,020
| +9% | +$837K |
|
1962
Healthcare Services Group
HCSG
$1.53B
| $9.74M | ﹤0.01% |
965,843
+74,476
| +8% | +$816K |
|
1963
US Physical Therapy
USPH
$1.22B
| $9.73M | ﹤0.01% |
134,498
-7,169
| -5% | -$602K |
|
1964
Astec Industries
ASTE
$1.02B
| $9.73M | ﹤0.01% |
282,394
+17,444
| +7% | +$600K |
|
1965
Enovix
ENVX
$1.03B
| $9.73M | ﹤0.01% |
1,514,625
-26,335
| -2% | -$234K |
|
1966
QCR Holdings
QCRH
$1.7B
| $9.73M | ﹤0.01% |
136,380
-9,610
| -7% | -$732K |
|
1967
Celldex Therapeutics
CLDX
$3.27B
| $9.73M | ﹤0.01% |
535,844
-8,486
| -2% | -$190K |
|
1968
Unitil
UTL
$980M
| $9.72M | ﹤0.01% |
168,461
-3,751
| -2% | -$206K |
|
1969
Barrett Business Services
BBSI
$804M
| $9.69M | ﹤0.01% |
235,464
-14,078
| -6% | -$587K |
|
1970
Evolent Health
EVH
$444M
| $9.69M | ﹤0.01% |
1,023,077
+104,085
| +11% | +$1.05M |
|
1971
Disc Medicine
IRON
$2.97B
| $9.67M | ﹤0.01% |
194,725
+29,653
| +18% | +$1.65M |
|
1972
Arlo Technologies
ARLO
$1.65B
| $9.66M | ﹤0.01% |
978,521
-68,384
| -7% | -$781K |
|
1973
Protolabs
PRLB
$2.13B
| $9.6M | ﹤0.01% |
274,038
-15,307
| -5% | -$603K |
|
1974
Deluxe
DLX
$1.15B
| $9.55M | ﹤0.01% |
603,894
-20,440
| -3% | -$387K |
|
1975
Select Water Solutions
WTTR
$2.8B
| $9.52M | ﹤0.01% |
906,845
-8,367
| -0.9% | -$102K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.